|
|
||||||||

* Department of Pathology, St. Louis University School of Medicine, St. Louis, MO 63104; and
Veterans Administration Medical Center, St. Louis, MO 63106
NK lytic-associated molecule (NKLAM) is a protein involved in the cytolytic function of NK cells and CTLs. It has been localized to the cytolytic granules in NK cells and is up-regulated when cells are exposed to cytokines IL-2 or IFN-
. We report in this study that NKLAM contains a cysteine-rich really interesting new gene (RING) in between RING-RING domain, and that this domain possesses strong homology to the RING domain of the known E3 ubiquitin ligase, Dorfin. To determine whether NKLAM functions as an E3 ligase, we performed coimmunoprecipitation binding assays with ubiquitin conjugates (Ubcs) UbcH7, UbcH8, and UbcH10. We demonstrated that both UbcH7 and UbcH8 bind to full-length NKLAM. We then performed a similar binding assay using endogenous NKLAM and UbcH8 expressed by human NK clone NK3.3 to show that the protein interaction occurs in vivo. Using the yeast two-hybrid system, we identified uridine kinase like-1 (URKL-1) protein as a substrate for NKLAM. We confirmed that NKLAM and URKL-1 interact in mammalian cells by using both immunoprecipitation and confocal microscopy. We demonstrated decreased protein expression and enhanced ubiquitination of URKL-1 in the presence of NKLAM. These data indicate that NKLAM is a RING finger protein that binds Ubcs and has as one of its substrates, URKL-1, thus defining this cytolytic protein as an E3 ubiquitin ligase.
This article has been cited by other articles:
![]() |
E. A. Whitcomb, E. J. Dudek, Q. Liu, and A. Taylor Novel Control of S Phase of the Cell Cycle by Ubiquitin-conjugating Enzyme H7 Mol. Biol. Cell, January 1, 2009; 20(1): 1 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Durfee, M. L. Kelley, and J. M. Huibregtse The Basis for Selective E1-E2 Interactions in the ISG15 Conjugation System J. Biol. Chem., August 29, 2008; 283(35): 23895 - 23902. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |